Modulight Spotlights: LASER-SHARP RESEARCH – August 2023
Interleukin 15 (IL-15) is promising candidate for cancer immunotherapy, since it is an inducer of differentiation and proliferation of killer T cells and NK cells. A new study by Fukushima et al. at NCI, published in Molecular Cancer Therapeutics, shows increase in therapeutic efficacy in vivo when IL15 was combined with photoimmunotherapy using ML7710 laser system. Intratumoral injection of IL-15 also boosted the immune responses against both the primary tumor as well as abscopal effect eradicating distant, untreated tumor.
Modulight is very happy to be supporting this research. We would like to deliver our warmest congratulations to the research team!
#LaserSharpResearch #photoimmunotherapy #abscopaleffects #invitro #invivo #immunotherapy #combinationtherapy #interleukin15 #ML7710
Modulight products used:
ML7710 – a clinical laser platform
Read more:
In-vitro and in-vivo illumination »
About Modulight’s LASER-SHARP RESEARCH concept:
Laser-Sharp Research is a concept where our scientific board highlights cutting-edge scientific research articles from our customers. Important selection criteria are that Modulight and laser product are mentioned in the publication, the impact and relevance of the results, clinical translatability, as well as scientific quality of the journal. The nominated research groups will be rewarded to encourage the great work done.
Contact Us
Do you have questions or comments related to this LASER-SHARP RESEARCH nomination? Maybe your group has done significant research that your would like us to spotlight? Or would you like to request literature? Please drop us a line!